Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

18F-labeled norepinephrine transporter tracer [18F]NS12137: radiosynthesis and preclinical evaluation

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. 68Ga-DOTATOC PET/CT in the localization of head and neck paraganglioma compared with 18F-DOPA PET/CT and 123I-MIBG SPECT/CT

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Synthesis and evaluation of (18)F-labeled 5-HT2A receptor agonists as PET ligands

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Automated synthesis and PET evaluation of both enantiomers of [¹⁸F]FMISO

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. The impact of weakly bound ⁸⁹Zr on preclinical studies: non-specific accumulation in solid tumors and aspergillus infection

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. In vivo characterization of a novel norepinephrine transporter PET tracer [18F]NS12137 in adult and immature Sprague-Dawley rats

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Anna K Kirjavainen
  • Sarita Forsback
  • Francisco R López-Picón
  • Päivi Marjamäki
  • Jatta Takkinen
  • Merja Haaparanta-Solin
  • Dan Peters
  • Olof Solin
Vis graf over relationer

INTRODUCTION: Several psychiatric and neurodegenerative diseases are associated with malfunction of brain norepinephrine transporter (NET). However, current clinical evaluations of NET function are limited by the lack of sufficiently sensitive methods of detection. To this end, we have synthesized exo-3-[(6-[18F]fluoro-2-pyridyl)oxy]-8-azabicyclo[3.2.1]-octane ([18F]NS12137) as a radiotracer for positron emission tomography (PET) and have demonstrated that it is highly specific for in vivo detection of NET-rich regions of rat brain tissue.

METHODS: We applied two methods of electrophilic, aromatic radiofluorination of the precursor molecule, exo-3-[(6-trimethylstannyl-2-pyridyl)oxy]-8-azabicyclo-[3.2.1]octane-8-carboxylate: (1) direct labeling with [18F]F2, and (2) labeling with [18F]Selectfluor, a derivative of [18F]F2, using post-target produced [18F]F2. The time-dependent distribution of [18F]NS12137 in brain tissue of healthy, adult Sprague-Dawley rats was determined by ex vivo autoradiography. The specificity of [18F]NS12137 binding was demonstrated on the basis of competitive binding by nisoxetine, a known NET antagonist of high specificity.

RESULTS: [18F]NS12137 was successfully synthesized with radiochemical yields of 3.9% ± 0.3% when labeled with [18F]F2 and 10.2% ± 2.7% when labeled with [18F]Selectfluor. The molar activity of radiotracer was 8.8 ± 0.7 GBq/μmol with [18F]F2 labeling and 6.9 ± 0.4 GBq/μmol with [18F]Selectfluor labeling at the end of synthesis of [18F]NS12137. Uptake of [18F]NS12137 in NET-rich areas in rat brain was demonstrated with the locus coeruleus (LCoe) having the highest regional uptake. Prior treatment of rats with nisoxetine showed no detectable [18F]NS12137 in the LCoe. Analyses of whole brain samples for radiometabolites showed only the parent compound [18F]NS12137. Uptake of 18F-radioactivity in bone increased with time.

CONCLUSIONS: The two electrophilic 18F-labeling methods proved to be suitable for synthesis of [18F]NS12137 with the [18F]Selectfluor method providing an approximate three-fold higher yield than the [18F]F2 method. As an electrostatically neutral radiotracer [18F]NS12137 crosses the blood-brain barrier and enabled specific labeling of NET-rich regions of rat brain tissue with the highest concentration in the LCoe.

OriginalsprogEngelsk
TidsskriftNuclear Medicine and Biology
Vol/bind56
Sider (fra-til)39-46
Antal sider8
ISSN0969-8051
DOI
StatusUdgivet - jan. 2018

ID: 56318933